Susquehanna International Group’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,742
Closed -$33K 14351
2025
Q4
$33K Buy
+37,742
New +$70.4K ﹤0.01% 11856
2023
Q4
Sell
-2,227
Closed -$16.7K 13451
2023
Q3
$16.7K Buy
2,227
+1,118
+101% +$11.4K ﹤0.01% 11644
2023
Q2
$10.6K Sell
1,109
-1,326
-54% -$15K ﹤0.01% 11753
2023
Q1
$21.1K Buy
2,435
+1,640
+206% +$32.3K ﹤0.01% 12033
2022
Q4
$11.5K Sell
795
-608
-43% -$14.1K ﹤0.01% 11912
2022
Q3
$40K Buy
1,403
+334
+31% +$12.3K ﹤0.01% 12338
2022
Q2
$43K Buy
+1,069
New +$103K ﹤0.01% 12060

Other funds holding AIFF

Susquehanna International Group's AIFF Position: Q1 2026 in Review

Susquehanna International Group sold out of Firefly Neuroscience (AIFF) in Q1 2026, closing a stake of 37,742 shares — an estimated $33K sold.

Susquehanna International Group first reported a position in AIFF in Q2 2022 and held it in 7 quarters. The position peaked at $43K in Q2 2022. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • Susquehanna International Group reported no remaining Firefly Neuroscience position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 37,742 Firefly Neuroscience shares in Q1 2026, an estimated $33K.
  • Susquehanna International Group first reported a position in Firefly Neuroscience in Q2 2022 and held it in 7 quarters.
  • Susquehanna International Group's Firefly Neuroscience position peaked at $43K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.